Tempest Therapeutics, Inc. (TPST)
1.89
+0.05
(+2.72%)
USD |
NASDAQ |
May 14, 09:55
Tempest Therapeutics EPS Diluted (Quarterly) : -0.8161 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | 1.023 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Anika Therapeutics, Inc. | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.021M |
| Total Expenses (Quarterly) | 4.021M |
| Enterprise Value | 26.83M |
| Earnings Yield | -361.7% |
| Normalized Earnings Yield | -361.66 |